id	sid	tid	token	lemma	pos
6w924b32f1m	1	1	this	this	DET
6w924b32f1m	1	2	dissertation	dissertation	NOUN
6w924b32f1m	1	3	demonstrates	demonstrate	VERB
6w924b32f1m	1	4	the	the	DET
6w924b32f1m	1	5	development	development	NOUN
6w924b32f1m	1	6	of	of	ADP
6w924b32f1m	1	7	optimized	optimize	VERB
6w924b32f1m	1	8	targeted	target	VERB
6w924b32f1m	1	9	liposomal	liposomal	ADJ
6w924b32f1m	1	10	nanoparticle	nanoparticle	NOUN
6w924b32f1m	1	11	formulation	formulation	NOUN
6w924b32f1m	1	12	for	for	ADP
6w924b32f1m	1	13	cancer	cancer	NOUN
6w924b32f1m	1	14	and	and	CCONJ
6w924b32f1m	1	15	inhibitors	inhibitor	NOUN
6w924b32f1m	1	16	for	for	ADP
6w924b32f1m	1	17	allergies	allergy	NOUN
6w924b32f1m	1	18	.	.	PUNCT
6w924b32f1m	2	1	the	the	DET
6w924b32f1m	2	2	first	first	ADJ
6w924b32f1m	2	3	part	part	NOUN
6w924b32f1m	2	4	(	(	PUNCT
6w924b32f1m	2	5	chapter	chapter	NOUN
6w924b32f1m	2	6	2	2	NUM
6w924b32f1m	2	7	-	-	SYM
6w924b32f1m	2	8	4	4	NUM
6w924b32f1m	2	9	)	)	PUNCT
6w924b32f1m	2	10	describes	describe	VERB
6w924b32f1m	2	11	the	the	DET
6w924b32f1m	2	12	approach	approach	NOUN
6w924b32f1m	2	13	to	to	ADP
6w924b32f1m	2	14	rationally	rationally	ADV
6w924b32f1m	2	15	engineered	engineer	VERB
6w924b32f1m	2	16	target	target	NOUN
6w924b32f1m	2	17	-	-	PUNCT
6w924b32f1m	2	18	specific	specific	ADJ
6w924b32f1m	2	19	liposomal	liposomal	ADJ
6w924b32f1m	2	20	nanoparticles	nanoparticle	NOUN
6w924b32f1m	2	21	for	for	ADP
6w924b32f1m	2	22	various	various	ADJ
6w924b32f1m	2	23	types	type	NOUN
6w924b32f1m	2	24	of	of	ADP
6w924b32f1m	2	25	cancers	cancer	NOUN
6w924b32f1m	2	26	,	,	PUNCT
6w924b32f1m	2	27	including	include	VERB
6w924b32f1m	2	28	breast	breast	NOUN
6w924b32f1m	2	29	cancer	cancer	NOUN
6w924b32f1m	2	30	and	and	CCONJ
6w924b32f1m	2	31	b	b	NOUN
6w924b32f1m	2	32	-	-	PUNCT
6w924b32f1m	2	33	cell	cell	NOUN
6w924b32f1m	2	34	malignancies	malignancy	NOUN
6w924b32f1m	2	35	.	.	PUNCT
6w924b32f1m	3	1	liposomal	liposomal	ADJ
6w924b32f1m	3	2	nanoparticles	nanoparticle	NOUN
6w924b32f1m	3	3	have	have	AUX
6w924b32f1m	3	4	been	be	AUX
6w924b32f1m	3	5	recognized	recognize	VERB
6w924b32f1m	3	6	and	and	CCONJ
6w924b32f1m	3	7	utilized	utilize	VERB
6w924b32f1m	3	8	as	as	ADP
6w924b32f1m	3	9	drug	drug	NOUN
6w924b32f1m	3	10	delivery	delivery	NOUN
6w924b32f1m	3	11	platforms	platform	NOUN
6w924b32f1m	3	12	for	for	ADP
6w924b32f1m	3	13	decades	decade	NOUN
6w924b32f1m	3	14	.	.	PUNCT
6w924b32f1m	4	1	nevertheless	nevertheless	ADV
6w924b32f1m	4	2	,	,	PUNCT
6w924b32f1m	4	3	many	many	ADJ
6w924b32f1m	4	4	attempts	attempt	NOUN
6w924b32f1m	4	5	to	to	PART
6w924b32f1m	4	6	translate	translate	VERB
6w924b32f1m	4	7	targeted	target	VERB
6w924b32f1m	4	8	liposomal	liposomal	ADJ
6w924b32f1m	4	9	formulations	formulation	NOUN
6w924b32f1m	4	10	as	as	ADP
6w924b32f1m	4	11	novel	novel	ADJ
6w924b32f1m	4	12	treatments	treatment	NOUN
6w924b32f1m	4	13	to	to	ADP
6w924b32f1m	4	14	the	the	DET
6w924b32f1m	4	15	clinic	clinic	NOUN
6w924b32f1m	4	16	have	have	AUX
6w924b32f1m	4	17	failed	fail	VERB
6w924b32f1m	4	18	.	.	PUNCT
6w924b32f1m	5	1	in	in	ADP
6w924b32f1m	5	2	fact	fact	NOUN
6w924b32f1m	5	3	,	,	PUNCT
6w924b32f1m	5	4	fda	fda	PROPN
6w924b32f1m	5	5	has	have	AUX
6w924b32f1m	5	6	n't	not	PART
6w924b32f1m	5	7	approved	approve	VERB
6w924b32f1m	5	8	any	any	DET
6w924b32f1m	5	9	targeted	target	VERB
6w924b32f1m	5	10	nanoparticle	nanoparticle	NOUN
6w924b32f1m	5	11	(	(	PUNCT
6w924b32f1m	5	12	liposomal	liposomal	ADJ
6w924b32f1m	5	13	or	or	CCONJ
6w924b32f1m	5	14	other	other	ADJ
6w924b32f1m	5	15	materials	material	NOUN
6w924b32f1m	5	16	)	)	PUNCT
6w924b32f1m	5	17	treatments	treatment	NOUN
6w924b32f1m	5	18	as	as	ADP
6w924b32f1m	5	19	of	of	ADP
6w924b32f1m	5	20	this	this	DET
6w924b32f1m	5	21	time	time	NOUN
6w924b32f1m	5	22	of	of	ADP
6w924b32f1m	5	23	writing	writing	NOUN
6w924b32f1m	5	24	.	.	PUNCT
6w924b32f1m	6	1	among	among	ADP
6w924b32f1m	6	2	many	many	ADJ
6w924b32f1m	6	3	reasons	reason	NOUN
6w924b32f1m	6	4	for	for	ADP
6w924b32f1m	6	5	failure	failure	NOUN
6w924b32f1m	6	6	,	,	PUNCT
6w924b32f1m	6	7	one	one	NUM
6w924b32f1m	6	8	of	of	ADP
6w924b32f1m	6	9	the	the	DET
6w924b32f1m	6	10	main	main	ADJ
6w924b32f1m	6	11	ones	one	NOUN
6w924b32f1m	6	12	regards	regard	VERB
6w924b32f1m	6	13	issues	issue	NOUN
6w924b32f1m	6	14	surrounding	surround	VERB
6w924b32f1m	6	15	consistent	consistent	ADJ
6w924b32f1m	6	16	reproducibility	reproducibility	NOUN
6w924b32f1m	6	17	of	of	ADP
6w924b32f1m	6	18	targeted	target	VERB
6w924b32f1m	6	19	nanomaterials	nanomaterial	NOUN
6w924b32f1m	6	20	during	during	ADP
6w924b32f1m	6	21	manufacturing	manufacturing	NOUN
6w924b32f1m	6	22	.	.	PUNCT
6w924b32f1m	7	1	to	to	PART
6w924b32f1m	7	2	address	address	VERB
6w924b32f1m	7	3	this	this	DET
6w924b32f1m	7	4	limitation	limitation	NOUN
6w924b32f1m	7	5	,	,	PUNCT
6w924b32f1m	7	6	our	our	PRON
6w924b32f1m	7	7	lab	lab	NOUN
6w924b32f1m	7	8	has	have	AUX
6w924b32f1m	7	9	developed	develop	VERB
6w924b32f1m	7	10	a	a	DET
6w924b32f1m	7	11	patented	patent	VERB
6w924b32f1m	7	12	technology	technology	NOUN
6w924b32f1m	7	13	for	for	ADP
6w924b32f1m	7	14	the	the	DET
6w924b32f1m	7	15	synthesis	synthesis	NOUN
6w924b32f1m	7	16	of	of	ADP
6w924b32f1m	7	17	peptide	peptide	NOUN
6w924b32f1m	7	18	-	-	PUNCT
6w924b32f1m	7	19	targeted	target	VERB
6w924b32f1m	7	20	liposomes	liposome	NOUN
6w924b32f1m	7	21	with	with	ADP
6w924b32f1m	7	22	highly	highly	ADV
6w924b32f1m	7	23	consistent	consistent	ADJ
6w924b32f1m	7	24	batch	batch	NOUN
6w924b32f1m	7	25	-	-	PUNCT
6w924b32f1m	7	26	to	to	ADP
6w924b32f1m	7	27	-	-	PUNCT
6w924b32f1m	7	28	batch	batch	NOUN
6w924b32f1m	7	29	production	production	NOUN
6w924b32f1m	7	30	that	that	PRON
6w924b32f1m	7	31	reproducibly	reproducibly	VERB
6w924b32f1m	7	32	achieves	achieve	VERB
6w924b32f1m	7	33	reliable	reliable	ADJ
6w924b32f1m	7	34	outcomes	outcome	NOUN
6w924b32f1m	7	35	in	in	ADP
6w924b32f1m	7	36	vivo	vivo	ADJ
6w924b32f1m	7	37	experiments	experiment	NOUN
6w924b32f1m	7	38	.	.	PUNCT
6w924b32f1m	8	1	furthermore	furthermore	ADV
6w924b32f1m	8	2	,	,	PUNCT
6w924b32f1m	8	3	by	by	ADP
6w924b32f1m	8	4	taking	take	VERB
6w924b32f1m	8	5	advantage	advantage	NOUN
6w924b32f1m	8	6	of	of	ADP
6w924b32f1m	8	7	multivalency	multivalency	NOUN
6w924b32f1m	8	8	in	in	ADP
6w924b32f1m	8	9	our	our	PRON
6w924b32f1m	8	10	design	design	NOUN
6w924b32f1m	8	11	and	and	CCONJ
6w924b32f1m	8	12	using	use	VERB
6w924b32f1m	8	13	weak	weak	ADJ
6w924b32f1m	8	14	-	-	PUNCT
6w924b32f1m	8	15	to	to	AUX
6w924b32f1m	8	16	-	-	PUNCT
6w924b32f1m	8	17	moderate	moderate	ADJ
6w924b32f1m	8	18	monovalent	monovalent	NOUN
6w924b32f1m	8	19	affinity	affinity	NOUN
6w924b32f1m	8	20	ligand	ligand	NOUN
6w924b32f1m	8	21	peptides	peptide	NOUN
6w924b32f1m	8	22	as	as	ADP
6w924b32f1m	8	23	the	the	DET
6w924b32f1m	8	24	targeting	targeting	NOUN
6w924b32f1m	8	25	elements	element	NOUN
6w924b32f1m	8	26	,	,	PUNCT
6w924b32f1m	8	27	we	we	PRON
6w924b32f1m	8	28	are	be	AUX
6w924b32f1m	8	29	able	able	ADJ
6w924b32f1m	8	30	to	to	PART
6w924b32f1m	8	31	achieve	achieve	VERB
6w924b32f1m	8	32	selectivity	selectivity	NOUN
6w924b32f1m	8	33	by	by	ADP
6w924b32f1m	8	34	designing	design	VERB
6w924b32f1m	8	35	avidity	avidity	NOUN
6w924b32f1m	8	36	for	for	ADP
6w924b32f1m	8	37	cancer	cancer	NOUN
6w924b32f1m	8	38	cells	cell	NOUN
6w924b32f1m	8	39	while	while	SCONJ
6w924b32f1m	8	40	avoiding	avoid	VERB
6w924b32f1m	8	41	healthy	healthy	ADJ
6w924b32f1m	8	42	cells	cell	NOUN
6w924b32f1m	8	43	/	/	SYM
6w924b32f1m	8	44	tissue	tissue	NOUN
6w924b32f1m	8	45	.	.	PUNCT
6w924b32f1m	9	1	this	this	PRON
6w924b32f1m	9	2	is	be	AUX
6w924b32f1m	9	3	accomplished	accomplish	VERB
6w924b32f1m	9	4	by	by	ADP
6w924b32f1m	9	5	evaluating	evaluate	VERB
6w924b32f1m	9	6	the	the	DET
6w924b32f1m	9	7	liposomal	liposomal	ADJ
6w924b32f1m	9	8	formulation	formulation	NOUN
6w924b32f1m	9	9	first	first	ADV
6w924b32f1m	9	10	in	in	ADP
6w924b32f1m	9	11	vitro	vitro	X
6w924b32f1m	9	12	,	,	PUNCT
6w924b32f1m	9	13	and	and	CCONJ
6w924b32f1m	9	14	then	then	ADV
6w924b32f1m	9	15	further	far	ADV
6w924b32f1m	9	16	optimizing	optimize	VERB
6w924b32f1m	9	17	it	it	PRON
6w924b32f1m	9	18	in	in	ADP
6w924b32f1m	9	19	vivo	vivo	NOUN
6w924b32f1m	9	20	by	by	ADP
6w924b32f1m	9	21	adjusting	adjust	VERB
6w924b32f1m	9	22	the	the	DET
6w924b32f1m	9	23	individual	individual	ADJ
6w924b32f1m	9	24	design	design	NOUN
6w924b32f1m	9	25	parameters	parameter	NOUN
6w924b32f1m	9	26	,	,	PUNCT
6w924b32f1m	9	27	such	such	ADJ
6w924b32f1m	9	28	as	as	ADP
6w924b32f1m	9	29	peptide	peptide	NOUN
6w924b32f1m	9	30	density	density	NOUN
6w924b32f1m	9	31	,	,	PUNCT
6w924b32f1m	9	32	linker	linker	PROPN
6w924b32f1m	9	33	length	length	NOUN
6w924b32f1m	9	34	,	,	PUNCT
6w924b32f1m	9	35	peptide	peptide	NOUN
6w924b32f1m	9	36	hydrophilicity	hydrophilicity	NOUN
6w924b32f1m	9	37	,	,	PUNCT
6w924b32f1m	9	38	and	and	CCONJ
6w924b32f1m	9	39	particle	particle	NOUN
6w924b32f1m	9	40	size	size	NOUN
6w924b32f1m	9	41	,	,	PUNCT
6w924b32f1m	9	42	to	to	PART
6w924b32f1m	9	43	achieve	achieve	VERB
6w924b32f1m	9	44	maximal	maximal	ADJ
6w924b32f1m	9	45	cellular	cellular	ADJ
6w924b32f1m	9	46	uptake	uptake	NOUN
6w924b32f1m	9	47	while	while	SCONJ
6w924b32f1m	9	48	preserving	preserve	VERB
6w924b32f1m	9	49	the	the	DET
6w924b32f1m	9	50	selectivity	selectivity	NOUN
6w924b32f1m	9	51	for	for	ADP
6w924b32f1m	9	52	specific	specific	ADJ
6w924b32f1m	9	53	target	target	NOUN
6w924b32f1m	9	54	cancer	cancer	NOUN
6w924b32f1m	9	55	cells	cell	NOUN
6w924b32f1m	9	56	.	.	PUNCT
6w924b32f1m	10	1	in	in	ADP
6w924b32f1m	10	2	each	each	DET
6w924b32f1m	10	3	chapter	chapter	NOUN
6w924b32f1m	10	4	,	,	PUNCT
6w924b32f1m	10	5	we	we	PRON
6w924b32f1m	10	6	show	show	VERB
6w924b32f1m	10	7	optimized	optimize	VERB
6w924b32f1m	10	8	targeted	target	VERB
6w924b32f1m	10	9	liposomal	liposomal	ADJ
6w924b32f1m	10	10	nanoparticles	nanoparticle	NOUN
6w924b32f1m	10	11	that	that	PRON
6w924b32f1m	10	12	achieved	achieve	VERB
6w924b32f1m	10	13	enhanced	enhanced	ADJ
6w924b32f1m	10	14	therapeutic	therapeutic	ADJ
6w924b32f1m	10	15	efficacy	efficacy	NOUN
6w924b32f1m	10	16	to	to	PART
6w924b32f1m	10	17	significantly	significantly	ADV
6w924b32f1m	10	18	inhibit	inhibit	VERB
6w924b32f1m	10	19	tumor	tumor	NOUN
6w924b32f1m	10	20	growth	growth	NOUN
6w924b32f1m	10	21	with	with	ADP
6w924b32f1m	10	22	reduced	reduce	VERB
6w924b32f1m	10	23	toxicity.the	toxicity.the	DET
6w924b32f1m	10	24	second	second	ADJ
6w924b32f1m	10	25	part	part	NOUN
6w924b32f1m	10	26	(	(	PUNCT
6w924b32f1m	10	27	chapter	chapter	NOUN
6w924b32f1m	10	28	5	5	NUM
6w924b32f1m	10	29	and	and	CCONJ
6w924b32f1m	10	30	6	6	NUM
6w924b32f1m	10	31	)	)	PUNCT
6w924b32f1m	10	32	describes	describe	VERB
6w924b32f1m	10	33	the	the	DET
6w924b32f1m	10	34	development	development	NOUN
6w924b32f1m	10	35	of	of	ADP
6w924b32f1m	10	36	allergen	allergen	ADJ
6w924b32f1m	10	37	-	-	PUNCT
6w924b32f1m	10	38	specific	specific	ADJ
6w924b32f1m	10	39	inhibitors	inhibitor	NOUN
6w924b32f1m	10	40	.	.	PUNCT
6w924b32f1m	11	1	allergic	allergic	ADJ
6w924b32f1m	11	2	reactions	reaction	NOUN
6w924b32f1m	11	3	can	can	AUX
6w924b32f1m	11	4	vary	vary	VERB
6w924b32f1m	11	5	from	from	ADP
6w924b32f1m	11	6	mild	mild	ADJ
6w924b32f1m	11	7	(	(	PUNCT
6w924b32f1m	11	8	rash	rash	ADJ
6w924b32f1m	11	9	,	,	PUNCT
6w924b32f1m	11	10	itchiness	itchiness	NOUN
6w924b32f1m	11	11	,	,	PUNCT
6w924b32f1m	11	12	runny	runny	ADJ
6w924b32f1m	11	13	nose	nose	NOUN
6w924b32f1m	11	14	,	,	PUNCT
6w924b32f1m	11	15	etc	etc	X
6w924b32f1m	11	16	.	.	X
6w924b32f1m	11	17	)	)	PUNCT
6w924b32f1m	11	18	to	to	ADP
6w924b32f1m	11	19	a	a	DET
6w924b32f1m	11	20	life	life	NOUN
6w924b32f1m	11	21	-	-	PUNCT
6w924b32f1m	11	22	threatening	threaten	VERB
6w924b32f1m	11	23	anaphylaxis	anaphylaxis	ADJ
6w924b32f1m	11	24	.	.	PUNCT
6w924b32f1m	12	1	currently	currently	ADV
6w924b32f1m	12	2	,	,	PUNCT
6w924b32f1m	12	3	there	there	PRON
6w924b32f1m	12	4	are	be	VERB
6w924b32f1m	12	5	no	no	DET
6w924b32f1m	12	6	prophylactic	prophylactic	ADJ
6w924b32f1m	12	7	treatments	treatment	NOUN
6w924b32f1m	12	8	available	available	ADJ
6w924b32f1m	12	9	that	that	PRON
6w924b32f1m	12	10	prevents	prevent	VERB
6w924b32f1m	12	11	the	the	DET
6w924b32f1m	12	12	allergic	allergic	ADJ
6w924b32f1m	12	13	reaction	reaction	NOUN
6w924b32f1m	12	14	prior	prior	ADV
6w924b32f1m	12	15	to	to	ADP
6w924b32f1m	12	16	its	its	PRON
6w924b32f1m	12	17	initiation	initiation	NOUN
6w924b32f1m	12	18	.	.	PUNCT
6w924b32f1m	13	1	to	to	PART
6w924b32f1m	13	2	address	address	VERB
6w924b32f1m	13	3	this	this	DET
6w924b32f1m	13	4	problem	problem	NOUN
6w924b32f1m	13	5	,	,	PUNCT
6w924b32f1m	13	6	we	we	PRON
6w924b32f1m	13	7	developed	develop	VERB
6w924b32f1m	13	8	a	a	DET
6w924b32f1m	13	9	two	two	NUM
6w924b32f1m	13	10	-	-	PUNCT
6w924b32f1m	13	11	step	step	NOUN
6w924b32f1m	13	12	process	process	NOUN
6w924b32f1m	13	13	where	where	SCONJ
6w924b32f1m	13	14	we	we	PRON
6w924b32f1m	13	15	first	first	ADV
6w924b32f1m	13	16	identify	identify	VERB
6w924b32f1m	13	17	immunodominant	immunodominant	ADJ
6w924b32f1m	13	18	epitopes	epitope	NOUN
6w924b32f1m	13	19	/	/	SYM
6w924b32f1m	13	20	haptens	hapten	NOUN
6w924b32f1m	13	21	,	,	PUNCT
6w924b32f1m	13	22	and	and	CCONJ
6w924b32f1m	13	23	then	then	ADV
6w924b32f1m	13	24	develop	develop	VERB
6w924b32f1m	13	25	specific	specific	ADJ
6w924b32f1m	13	26	inhibitors	inhibitor	NOUN
6w924b32f1m	13	27	for	for	ADP
6w924b32f1m	13	28	these	these	DET
6w924b32f1m	13	29	epitopes	epitope	NOUN
6w924b32f1m	13	30	/	/	SYM
6w924b32f1m	13	31	haptens	hapten	NOUN
6w924b32f1m	13	32	.	.	PUNCT
6w924b32f1m	14	1	we	we	PRON
6w924b32f1m	14	2	start	start	VERB
6w924b32f1m	14	3	by	by	ADP
6w924b32f1m	14	4	using	use	VERB
6w924b32f1m	14	5	our	our	PRON
6w924b32f1m	14	6	patented	patented	ADJ
6w924b32f1m	14	7	liposome	liposome	NOUN
6w924b32f1m	14	8	-	-	PUNCT
6w924b32f1m	14	9	based	base	VERB
6w924b32f1m	14	10	synthetic	synthetic	ADJ
6w924b32f1m	14	11	allergen	allergen	NOUN
6w924b32f1m	14	12	platform	platform	NOUN
6w924b32f1m	14	13	,	,	PUNCT
6w924b32f1m	14	14	named	name	VERB
6w924b32f1m	14	15	nanoallergens	nanoallergens	PROPN
6w924b32f1m	14	16	,	,	PUNCT
6w924b32f1m	14	17	to	to	PART
6w924b32f1m	14	18	identify	identify	VERB
6w924b32f1m	14	19	immunogenic	immunogenic	ADJ
6w924b32f1m	14	20	epitopes	epitope	NOUN
6w924b32f1m	14	21	that	that	PRON
6w924b32f1m	14	22	are	be	AUX
6w924b32f1m	14	23	responsible	responsible	ADJ
6w924b32f1m	14	24	for	for	ADP
6w924b32f1m	14	25	triggering	trigger	VERB
6w924b32f1m	14	26	the	the	DET
6w924b32f1m	14	27	degranulation	degranulation	NOUN
6w924b32f1m	14	28	response	response	NOUN
6w924b32f1m	14	29	.	.	PUNCT
6w924b32f1m	15	1	then	then	ADV
6w924b32f1m	15	2	,	,	PUNCT
6w924b32f1m	15	3	using	use	VERB
6w924b32f1m	15	4	the	the	DET
6w924b32f1m	15	5	identified	identify	VERB
6w924b32f1m	15	6	immunogenic	immunogenic	ADJ
6w924b32f1m	15	7	epitopes	epitope	NOUN
6w924b32f1m	15	8	,	,	PUNCT
6w924b32f1m	15	9	we	we	PRON
6w924b32f1m	15	10	develop	develop	VERB
6w924b32f1m	15	11	inhibitors	inhibitor	NOUN
6w924b32f1m	15	12	,	,	PUNCT
6w924b32f1m	15	13	named	name	VERB
6w924b32f1m	15	14	chbis	chbi	NOUN
6w924b32f1m	15	15	,	,	PUNCT
6w924b32f1m	15	16	that	that	PRON
6w924b32f1m	15	17	bind	bind	VERB
6w924b32f1m	15	18	to	to	ADP
6w924b32f1m	15	19	allergen	allergen	NOUN
6w924b32f1m	15	20	-	-	PUNCT
6w924b32f1m	15	21	specific	specific	ADJ
6w924b32f1m	15	22	iges	ige	NOUN
6w924b32f1m	15	23	and	and	CCONJ
6w924b32f1m	15	24	inhibit	inhibit	VERB
6w924b32f1m	15	25	their	their	PRON
6w924b32f1m	15	26	interaction	interaction	NOUN
6w924b32f1m	15	27	with	with	ADP
6w924b32f1m	15	28	the	the	DET
6w924b32f1m	15	29	allergen	allergen	NOUN
6w924b32f1m	15	30	and	and	CCONJ
6w924b32f1m	15	31	thereby	thereby	ADV
6w924b32f1m	15	32	inhibit	inhibit	VERB
6w924b32f1m	15	33	the	the	DET
6w924b32f1m	15	34	allergic	allergic	ADJ
6w924b32f1m	15	35	response	response	NOUN
6w924b32f1m	15	36	.	.	PUNCT
6w924b32f1m	16	1	in	in	ADP
6w924b32f1m	16	2	the	the	DET
6w924b32f1m	16	3	chapter	chapter	NOUN
6w924b32f1m	16	4	5	5	NUM
6w924b32f1m	16	5	,	,	PUNCT
6w924b32f1m	16	6	we	we	PRON
6w924b32f1m	16	7	demonstrated	demonstrate	VERB
6w924b32f1m	16	8	in	in	ADP
6w924b32f1m	16	9	vivo	vivo	ADJ
6w924b32f1m	16	10	efficacy	efficacy	NOUN
6w924b32f1m	16	11	of	of	ADP
6w924b32f1m	16	12	chbis	chbi	NOUN
6w924b32f1m	16	13	that	that	PRON
6w924b32f1m	16	14	effectively	effectively	ADV
6w924b32f1m	16	15	and	and	CCONJ
6w924b32f1m	16	16	persistently	persistently	ADV
6w924b32f1m	16	17	inhibit	inhibit	VERB
6w924b32f1m	16	18	ara	ara	PROPN
6w924b32f1m	16	19	h	h	NOUN
6w924b32f1m	16	20	2	2	ADV
6w924b32f1m	16	21	-	-	PUNCT
6w924b32f1m	16	22	induced	induce	VERB
6w924b32f1m	16	23	anaphylaxis	anaphylaxis	ADJ
6w924b32f1m	16	24	in	in	ADP
6w924b32f1m	16	25	the	the	DET
6w924b32f1m	16	26	humanized	humanize	VERB
6w924b32f1m	16	27	mice	mouse	NOUN
6w924b32f1m	16	28	.	.	PUNCT
6w924b32f1m	17	1	furthermore	furthermore	ADV
6w924b32f1m	17	2	,	,	PUNCT
6w924b32f1m	17	3	in	in	ADP
6w924b32f1m	17	4	the	the	DET
6w924b32f1m	17	5	chapter	chapter	NOUN
6w924b32f1m	17	6	6	6	NUM
6w924b32f1m	17	7	,	,	PUNCT
6w924b32f1m	17	8	we	we	PRON
6w924b32f1m	17	9	identified	identify	VERB
6w924b32f1m	17	10	immunogenic	immunogenic	ADJ
6w924b32f1m	17	11	epitopes	epitope	NOUN
6w924b32f1m	17	12	of	of	ADP
6w924b32f1m	17	13	shrimp	shrimp	NOUN
6w924b32f1m	17	14	protein	protein	NOUN
6w924b32f1m	17	15	,	,	PUNCT
6w924b32f1m	17	16	pen	pen	VERB
6w924b32f1m	17	17	a	a	DET
6w924b32f1m	17	18	1	1	NUM
6w924b32f1m	17	19	,	,	PUNCT
6w924b32f1m	17	20	and	and	CCONJ
6w924b32f1m	17	21	developed	develop	VERB
6w924b32f1m	17	22	a	a	DET
6w924b32f1m	17	23	cocktail	cocktail	NOUN
6w924b32f1m	17	24	of	of	ADP
6w924b32f1m	17	25	chbis	chbi	NOUN
6w924b32f1m	17	26	that	that	PRON
6w924b32f1m	17	27	showed	show	VERB
6w924b32f1m	17	28	more	more	ADJ
6w924b32f1m	17	29	than	than	ADP
6w924b32f1m	17	30	90	90	NUM
6w924b32f1m	17	31	%	%	NOUN
6w924b32f1m	17	32	inhibition	inhibition	NOUN
6w924b32f1m	17	33	in	in	ADP
6w924b32f1m	17	34	the	the	DET
6w924b32f1m	17	35	in	in	ADP
6w924b32f1m	17	36	vitro	vitro	X
6w924b32f1m	17	37	cellular	cellular	ADJ
6w924b32f1m	17	38	degranulation	degranulation	NOUN
6w924b32f1m	17	39	response	response	NOUN
6w924b32f1m	17	40	.	.	PUNCT